Gao Hanlin

Chief Scientific Officer

Gao Hanlin has filed 14 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2025. 13 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Gao Hanlin is listed as Chief Scientific Officer at Fulgent Genetics, Inc. Inside the rolling window, Gao Hanlin reported no open-market purchases and 7 open-market sales totaling $173K in FLGT. The largest disclosed transaction in the window is a sale of 1,673 FLGT shares on Sep 2, 2026, worth $33K.

Companies traded

Other insiders at FLGT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$173K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
FLGTSale$33KSep 3SEC ↗
FLGTSale$19KAug 28SEC ↗
FLGTSale$30KJun 3SEC ↗
FLGTSale$17KMay 28SEC ↗
FLGTSale$30KDec 3SEC ↗
FLGTSale$28KDec 1SEC ↗
FLGTSale$16KNov 25SEC ↗
Showing 1–7 of 7
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 3, 2025FLGTSale$23K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Gao Hanlin made?

Gao Hanlin has filed 14 SEC Form 4 filings (23 transaction rows) across 1 company since 2025.

Which companies does Gao Hanlin trade?

Gao Hanlin has filed SEC Form 4 disclosures for 1 company, including FLGT.

When was Gao Hanlin's most recent SEC Form 4 filing?

Gao Hanlin's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Gao Hanlin's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Gao Hanlin is listed as Chief Scientific Officer.

What is Gao Hanlin's total buy and sell value in the current window?

Inside the rolling retention window, Gao Hanlin bought $0 and sold $173K based on SEC Form 4 filings.

What was Gao Hanlin's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 1,673 FLGT shares on 2026-09-02, worth $33K, per SEC Form 4 filings.